Literature DB >> 28467211

Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.

Matthew D Cykowski, Suzanne Z Powell, Paul E Schulz, Hidehiro Takei, Andreana L Rivera, Robert E Jackson, Gustavo Roman, Gregory A Jicha, Peter T Nelson1.   

Abstract

CONTEXT: - Autopsy studies of the older population (≥65 years of age), and particularly of the "oldest-old" (≥85 years of age), have identified a significant proportion (∼20%) of cognitively impaired patients in which hippocampal sclerosis is the major substrate of an amnestic syndrome. Hippocampal sclerosis may also be comorbid with frontotemporal lobar degeneration, Alzheimer disease, and Lewy body disease. Until recently, the terms hippocampal sclerosis of aging or hippocampal sclerosis dementia were applied in this context. Recent discoveries have prompted a conceptual expansion of hippocampal sclerosis of aging because (1) cellular inclusions of TAR DNA-binding protein 43 kDa (TDP-43) are frequent; (2) TDP-43 pathology may be found outside hippocampus; and (3) brain arteriolosclerosis is a common, possibly pathogenic, component.
OBJECTIVE: - To aid pathologists with recent recommendations for diagnoses of common neuropathologies in older persons, particularly hippocampal sclerosis, and highlight the recent shift in diagnostic terminology from HS-aging to cerebral age-related TDP-43 with sclerosis (CARTS). DATA SOURCES: - Peer-reviewed literature and 5 autopsy examples that illustrate common age-related neuropathologies, including CARTS, and emphasize the importance of distinguishing CARTS from late-onset frontotemporal lobar degeneration with TDP-43 pathology and from advanced Alzheimer disease with TDP-43 pathology.
CONCLUSIONS: - In advanced old age, the substrates of cognitive impairment are often multifactorial. This article demonstrates common and frequently comorbid neuropathologic substrates of cognitive impairment in the older population, including CARTS, to aid those practicing in this area of pathology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28467211      PMCID: PMC5922266          DOI: 10.5858/arpa.2016-0469-SA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  39 in total

1.  Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Authors:  Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

2.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

3.  Estimating the number of persons with frontotemporal lobar degeneration in the US population.

Authors:  David S Knopman; Rosebud O Roberts
Journal:  J Mol Neurosci       Date:  2011-05-17       Impact factor: 3.444

Review 4.  Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature.

Authors:  Eseosa T Ighodaro; Gregory A Jicha; Frederick A Schmitt; Janna H Neltner; Erin L Abner; Richard J Kryscio; Charles D Smith; Taylor Duplessis; Sonya Anderson; Ela Patel; Adam Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

5.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

6.  TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.

Authors:  Keith A Josephs; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Amanda M Liesinger; Leonard Petrucelli; Matthew L Senjem; Robert J Ivnik; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson
Journal:  Ann Neurol       Date:  2015-09-16       Impact factor: 10.422

7.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2007-12-18       Impact factor: 17.088

9.  Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.

Authors:  Willa D Brenowitz; Sarah E Monsell; Frederick A Schmitt; Walter A Kukull; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.

Authors:  Gary W Beecham; Kara Hamilton; Adam C Naj; Eden R Martin; Matt Huentelman; Amanda J Myers; Jason J Corneveaux; John Hardy; Jean-Paul Vonsattel; Steven G Younkin; David A Bennett; Philip L De Jager; Eric B Larson; Paul K Crane; M Ilyas Kamboh; Julia K Kofler; Deborah C Mash; Linda Duque; John R Gilbert; Harry Gwirtsman; Joseph D Buxbaum; Patricia Kramer; Dennis W Dickson; Lindsay A Farrer; Matthew P Frosch; Bernardino Ghetti; Jonathan L Haines; Bradley T Hyman; Walter A Kukull; Richard P Mayeux; Margaret A Pericak-Vance; Julie A Schneider; John Q Trojanowski; Eric M Reiman; Gerard D Schellenberg; Thomas J Montine
Journal:  PLoS Genet       Date:  2014-09-04       Impact factor: 5.917

View more
  11 in total

1.  FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.

Authors:  Hugo Botha; William G Mantyh; Melissa E Murray; David S Knopman; Scott A Przybelski; Heather J Wiste; Jonathan Graff-Radford; Keith A Josephs; Christopher G Schwarz; Walter K Kremers; Bradley F Boeve; Ronald C Petersen; Mary M Machulda; Joseph E Parisi; Dennis W Dickson; Val Lowe; Clifford R Jack; David T Jones
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

2.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

Review 3.  The Role of TDP-43 in Neurodegenerative Disease.

Authors:  Yan-Zhe Liao; Jing Ma; Jie-Zhi Dou
Journal:  Mol Neurobiol       Date:  2022-05-02       Impact factor: 5.590

4.  Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias.

Authors:  Lei Yu; Patricia A Boyle; Aliza P Wingo; Jingyun Yang; Tianhao Wang; Aron S Buchman; Thomas S Wingo; Nicholas T Seyfried; Allan I Levey; Philip L De Jager; Julie A Schneider; David A Bennett
Journal:  Neurology       Date:  2021-12-22       Impact factor: 9.910

Review 5.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

6.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.

Authors:  Peter T Nelson; Zsombor Gal; Wang-Xia Wang; Dana M Niedowicz; Sergey C Artiushin; Samuel Wycoff; Angela Wei; Gregory A Jicha; David W Fardo
Journal:  Neurobiol Dis       Date:  2019-01-23       Impact factor: 5.996

Review 8.  Cognitive Impairment in Older Adults and Therapeutic Strategies.

Authors:  Thomas J Montine; Syed A Bukhari; Lon R White
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

9.  Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation.

Authors:  Thomas D Prevot; Akiko Sumitomo; Toshifumi Tomoda; Daniel E Knutson; Guanguan Li; Prithu Mondal; Mounira Banasr; James M Cook; Etienne Sibille
Journal:  Cereb Cortex       Date:  2021-01-05       Impact factor: 5.357

Review 10.  The neuropathological diagnosis of Alzheimer's disease.

Authors:  Michael A DeTure; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2019-08-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.